Lamictal and Kyphosis - a phase IV clinical study of FDA data

Summary:

Kyphosis is reported as a side effect among people who take Lamictal (lamotrigine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Zoloft, and have Osteoporosis.

The phase IV clinical study analyzes which people have Kyphosis when taking Lamictal. It is created by eHealthMe based on reports of 74,218 people who have side effects when taking Lamictal from the FDA, and is updated regularly.

What is Lamictal?

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 82,627 Lamictal users. Check the latest studies of Lamictal.

What is Kyphosis?

Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back)) is found to be associated with 656 drugs and 733 conditions by eHealthMe. Check the latest studies of Kyphosis.

On May, 22, 2026

74,218 people reported to have side effects when taking Lamictal.
Among them, 20 people (0.03%) have Kyphosis.

Among these 20 people:

How long have people been on Lamictal when they have Kyphosis? *

What is the gender of people who have Kyphosis when taking Lamictal? *

female: 76.47 %
male: 23.53 %

What is the age of people who have Kyphosis when taking Lamictal? *

What are other drugs people take besides Lamictal? *

What are other side effects people have besides Kyphosis? *

Osteoporosis (bones weak and more likely to break): 15 people, 75.00%
Cataract (clouding of the lens inside the eye): 12 people, 60.00%
Back Pain: 11 people, 55.00%
Fall: 11 people, 55.00%
Stress And Anxiety: 10 people, 50.00%
Osteopenia (a condition where bone mineral density is lower than normal): 9 people, 45.00%
High Blood Pressure: 9 people, 45.00%
Rib Fracture: 8 people, 40.00%
Weakness: 8 people, 40.00%
Dyspnea (difficult or laboured breathing): 8 people, 40.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 30.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 25.00%
Multiple Myeloma (cancer of the plasma cells): 4 people, 20.00%
Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 15.00%
Upper Respiratory Tract Infection: 2 people, 10.00%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 2 people, 10.00%
Muscle Spasms (muscle contraction): 2 people, 10.00%
Neoplasm Malignant (cancer tumour): 2 people, 10.00%
Acne (skin problems that cause pimples): 2 people, 10.00%
Pain: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lamictal and have Kyphosis?

- Check whether Kyphosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamictal:

Lamictal (82,627 reports)

Kyphosis treatments and more:

Kyphosis (3,242 reports)

Browse all side effects of Lamictal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Kyphosis:

Kyphosis (656 drugs)

Browse all the conditions that are associated with Kyphosis:

Kyphosis (733 conditions)

Related publications that referenced our studies

Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamictal) and Lamictal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.